Aldeyra Therapeutics (ALDX) Tops Q1 EPS by 6c

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q1 EPS of ($0.32), $0.06 better than the analyst estimate of ($0.38).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• AeroVironment restates quarterly financials, citing $89M goodwill error